In lymphoma, the expression of METTL14 is also considered an important prognostic indicator, which related to the degree of tumor differentiation and patients’ survival rate, with low expression of METTL14 potentially indicating poorer clinical outcomes (54). Here, METTL14 is linked to neoplasm.